Table 3.
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
Model 1 (1,054 observations) | Model 2 (680 observations) | |||||
OR (95% CI) | p‐value | aOR (95% CI) | p‐value | aOR (95% CI) | p‐value | |
Baseline characteristics | ||||||
Age (ref ≤30) | 1.02 (0.99 to 1.06) | 0.214 | ||||
In stable relationship | 0.69 (0.47 to 1.02) | 0.061 | ||||
Education (Above college vs. college graduate or below) | 1.57 (0.96 to 2.56) | 0.074 | ||||
Salary (≥1,000 USD vs. <1,000 USD) | 1.07 (0.72 to 1.60) | 0.728 | ||||
PEP in the past year | 1.64 (0.86 to 3.12) | 0.130 | ||||
Time‐varying variables a | ||||||
Time (days) b | 1.00 (1.00 to 1.00) | 0.615 | 1.00 (1.00 to 1.02) | 0.983 | ||
Anxiety (≥10 vs. <10) c | 0.46(0.24 to 0.90) | 0.023* | 0.70 (0.30 to 1.67) | 0.422 | 0.58 (0.18 to 1.88) | 0.364 |
Depression (≥15 vs. <15) d | 0.35 (0.14 to 0.87) | 0.025* | 0.58 (0.17 to 1.96) | 0.379 | 0.55 (0.11 to 2.64) | 0.453 |
Had STI | 0.76 (0.46 to 1.26) | 0.286 | ||||
Number of anal sex partners in the past month (ref = 0) | ||||||
1 | 1.41 (0.83 to 2.40) | 0.206 | 1.40 (0.82 to 2.41) | 0.222 | 1.49 (0.75 to 2.96) | 0.258 |
2 to 5 | 1.84 (1.07 to 3.17) | 0.027* | 2.07 (1.18 to 3.62) | 0.011* | 2.02 (0.98 to 4.15) | 0.056 |
>5 | 0.70 (0.34 to 1.41) | 0.317 | 0.84 (0.40 to 1.77) | 0.653 | 0.78 (0.30 to 2.06) | 0.617 |
Number of CAS in the past 4 weeks (≥5 vs. <5) e | 0.58 (0.32 to 1.05) | 0.072 | ||||
Alcohol use in the past month | 0.92 (0.51 to 1.67) | 0.782 | ||||
Sexualized drug use in the past month f | 0.50 (0.28 to 0.89) | 0.018* | 0.50 (0.27 to 0.94) | 0.031* | 0.62 (0.25 to 1.50) | 0.286 |
PrEP dosing regimen (Event‐driven vs. daily) | 0.58 (0.39 to 0.86) | 0.007** | 0.54 (0.36 to 0.81) | 0.003** | ||
Dosing regimens switch (ref= daily, no switch) | ||||||
Event‐driven, no switch | 0.61 (0.32 to −1.13) | 0.116 | 0.56 (0.30 to 1.06) | 0.071 | ||
Daily to event‐driven | 0.31 (0.15 to 0.63) | 0.001*** | 0.30 (0.15 to 0.63) | 0.001*** | ||
Event‐driven to daily | 0.47 (0.22 to 1.02) | 0.056 | 0.52 (0.24 to 1.15) | 0.105 |
Model 2 only included those participants who had data from more than one visit with 680 observations. The variables were the same as Model 1 except that Model 2 included dosing regimen switching rather than PrEP dosing regimen. AOR, adjusted odds ration; CAS, condomless anal sex; OR=odds ration; PEP, Post‐exposure Prophylaxis; STI, sexually transmitted infections.
Adjusted time since first self‐report PrEP initiation during the study period in univariate model
time: Since first self‐report PrEP initiation during the study period, unit: month
generalized anxiety disorder 7‐item (GAD‐7) scale score
patient health questionnaire (PHQ‐9) scale score
CAS: condomless anal sex
defined as use of methamphetamine or ecstasy or GHB/GBL or ketamine or mephedrone.
odds ratio significant at the p ≤ 0.05 level
odds ratio significant at the p ≤ 0.01 level
odds ratio significant at the p ≤ 0.001 level.